Life Therapeutics
Precision Immunotherapies Targeting Circulating Tumor Cells
Health Tech & Life Sciences
Stealth Mode
Company Overview
Snapshot
Founded in October 2023, Life Therapeutics operates with 1–10 employees. The company has secured funding across one round from one investor, Peregrine Ventures, in March 2024.
Business overview
Life Therapeutics is focused on developing precision immunotherapies that target circulating tumor cells. The company operates within the Health Tech & Life Sciences sector, specifically in Pharma & Medical Biotechnology, with a focus on Drugs Discovery & Development. Its core technology is centered on advanced immunotherapeutic approaches for oncology applications.
Log in to access full profile ›Company Intelligence Q&A
- When was Life Therapeutics founded?
- Life Therapeutics was founded in October 2023.
- What is Life Therapeutics' primary sector?
- Life Therapeutics' primary sector is Health Tech & Life Sciences, with a specialization in Pharma & Medical Biotechnology and Drugs Discovery & Development.
- How many employees does Life Therapeutics have?
- Life Therapeutics currently has 1–10 employees.
- Has Life Therapeutics raised any funding?
- In March 2024, Life Therapeutics secured a funding round from Peregrine Ventures.
- What is Life Therapeutics' product stage?
- Life Therapeutics is currently in the R&D product stage, focusing on advanced immunotherapeutic approaches for oncology applications.